CompletedPhase 4

Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome

United States50 participantsStarted 2004-06

Plain-language summary

Pulsed electromagnetic fields (PEMF) have been approved by FDA and are utilized currently in treating non-union fractures, neurogenic bladder and musculoskeletal pains. Based on 2 prior pilot studies (open label) demonstrating reduction in neuropathic pain from carpal tunnel syndrome we decided to perform a placebo-controlled trial, randomized for 2 months utilizing a wrist PEMF device attached by Velcro for 4 hours/day.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Intractable neuropathic pain in median nerve innervated hand for at least 3 months; * Abnormal neurological examination compatible with diagnosis of CTS Exclusion Criteria: * Post-surgical failures, * Pregnancy, * Pts with pacemaker

What they're measuring

VAS Pain scores 0-10 (leikert scale)

VAS Sleep interrupption 0-10

Neuropathic Pain scale (NPS)

Trial details

NCT IDNCT00277563

SponsorWeintraub, Michael I., MD, FACP, FAAN

Sponsor typeINDIV

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Refractory Carpal Tunnel Syndrome trials